Trend·igger

mrna

Search on Google

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Trending in 5 countries:

Peak volume

100+

First seen

2026-08-20

Last seen

2026-08-20

Days trending

1 / 1

Countries

5

Trending timeline

100+

Latest related news (2026-08-20)

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock more than doubles — CNBC
Moderna shares double on melanoma vaccine trial success — Financial Times
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial — STAT